Efalizumab and asthenia Patient Reports February 11, 2012

Efalizumab Side Effects Report #5050817-8
Efalizumab side effect was reported by a Physician from SWITZERLAND on June 29, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, arthritis , asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5122588-8
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Sept 22, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis , asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4836678-8
Efalizumab side effect was reported by a Health Professional from SWITZERLAND on Nov 03, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, asthenia, asthma , blood potassium increased, condition aggravated, eosinophil count increased, hypochromic anaemia, myalgia, oedema peripheral. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4852003-0
Efalizumab side effect was reported by a Consumer or non-health professional from BRAZIL on Nov 23, 2005. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #4917796-2
Efalizumab side effect was reported by a Physician from BRAZIL on Jan 30, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, arthralgia, arthritis , asthenia, asthma , blood potassium increased, condition aggravated, hypertension, lymphadenopathy. Efalizumab dosage: 0.142 MG/KG, 1/WEEK, SUBCUTANEOUS. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4998726-4
Efalizumab side effect was reported by a Physician from BRAZIL on May 05, 2006. Male patient, 46 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthritis , asthenia, asthma , basophil count increased, blood potassium increased, condition aggravated, eosinophil count increased, hypertension, hypochromic anaemia. Efalizumab dosage: 0.142 MG/KG, 1/WEEK. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4753508-3
Efalizumab side effect was reported by a Physician from AUSTRIA on Aug 15, 2005. Male patient, 40 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, fatigue, gamma-glutamyltransferase increased, hepatotoxicity, jaundice , malaise. Efalizumab dosage: 1 MG/KG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with ETANERCEPT. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #4622182-9
Efalizumab side effect was reported by a Consumer or non-health professional from on Mar 21, 2005. Male patient, 38 years of age, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: asthenia, myositis , paraesthesia. Efalizumab dosage: unknown. Patient recovered.

Efalizumab Side Effects Report #5129042-8
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Sept 22, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, arthralgia, asthenia, calcinosis, condition aggravated, diverticulum intestinal, granuloma, haemangioma of liver. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.


Efalizumab Side Effects Report #5156994-2
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, arthralgia, asthenia, diverticulum intestinal, inflammation, joint swelling, lymphocyte percentage decreased, neutrophil percentage increased. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5179367-5
Efalizumab side effect was reported by a Health Professional from UNITED STATES on Dec 05, 2006. Male patient, 28 years of age, weighting 155.4 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: anaemia, anorexia, asthenia, condition aggravated, diverticulum intestinal, haemangioma, inflammation, liver disorder, platelet count increased. Efalizumab dosage: 1 MG, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with PREDNISONE, CYCLOSPORINE, REMICADE, BENADRYL. Patient was hospitalized. Patient recovered.

Efalizumab Side Effects Report #5079943-4
Efalizumab side effect was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, 26 years of age, weighting 240.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: arthralgia, aspartate aminotransferase increased, asthenia, back pain , blood alkaline phosphatase increased, blood bilirubin increased, blood chloride increased, blood glucose increased, blood ph decreased. Efalizumab dosage: unknown. During the same period patient was treated with CLOBEX, COUMADIN, PROTOPIC OINTMENT, WELLBUTRIN, TOPICAL STEROIDS. Patient was hospitalized. Patient died on 06/30/2006.

Efalizumab Side Effects Report #5141724-0
Efalizumab side effect was reported by a Physician from UNITED STATES on Oct 19, 2006. Female patient, 26 years of age, weighting 240.3 lb, was diagnosed with psoriasis and was treated with Efalizumab. After drug was administered, patient experienced the following side effects: aggression, areflexia, arthralgia, aspartate aminotransferase increased, asthenia, back pain , blood alkaline phosphatase increased, blood bilirubin increased, blood chloride increased. Efalizumab dosage: 1.1 ML, 1/WEEK, SUBCUTANEOUS. During the same period patient was treated with CLOBEX, COUMADIN, PROTOPIC OINTMENT, WELLBUTRIN, TOPICAL STEROIDS. Patient was hospitalized. Patient died on 06/30/2006.